Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ida Robertsen"'
Autor:
Kine Eide Kvitne, Anders Åsberg, Line K. Johnson, Christine Wegler, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Rune Sandbu, Eva Skovlund, Hege Christensen, Rasmus Jansson‐Löfmark, Jøran Hjelmesæth, Ida Robertsen
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 11, Pp 2685-2696 (2022)
Abstract Previous studies have not accounted for the close link between type 2 diabetes mellitus (T2DM) and obesity when investigating the impact of T2DM on cytochrome P450 (CYP) activities. The aim was to investigate the effect of T2DM on in vivo ac
Externí odkaz:
https://doaj.org/article/1f0c72378b57453fa0275240cbd18d14
Autor:
Ole Martin Drevland, MSc, Ida Robertsen, PhD, Marte Theie Gustavsen, PhD, Hanne Kamilla Kveim, MSc, Markus Herberg Hovd, MSc, Karsten Midtvedt, MD, PhD, Anders Åsberg, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1448 (2023)
Background. Mycophenolate mofetil (MMF) is an immunosuppressive prodrug often used to prevent allograft rejection following solid organ transplantation. After oral administration, MMF is rapidly hydrolyzed to the active metabolite mycophenolate acid
Externí odkaz:
https://doaj.org/article/9550784b2a534c2389fd42020600e6ce
Autor:
Kine Eide Kvitne, Ida Robertsen, Eva Skovlund, Hege Christensen, Veronica Krogstad, Christine Wegler, Philip Carlo Angeles, Birgit Malene Wollmann, Kristine Hole, Line Kristin Johnson, Rune Sandbu, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Jøran Hjelmesæth, Rasmus Jansson‐Löfmark, Anders Åsberg
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 221-233 (2022)
Abstract It remains uncertain whether pharmacokinetic changes following Roux‐en‐Y gastric bypass (RYGB) can be attributed to surgery‐induced gastrointestinal alterations per se and/or the subsequent weight loss. The aim was to compare short‐
Externí odkaz:
https://doaj.org/article/94c01bed522b40c5b3bb33a9c5738373
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1073 (2023)
In combination with Bayesian estimates based on a population pharmacokinetic model, limited sampling strategies (LSS) may reduce the number of samples required for individual pharmacokinetic parameter estimations. Such strategies reduce the burden wh
Externí odkaz:
https://doaj.org/article/02e181529a1d41aa9c231317ab6f91c3
Autor:
Anders Åsberg, Anna Bjerre, Runar Almaas, Sergio Luis-Lima, Ida Robertsen, Cathrin Lytomt Salvador, Esteban Porrini, George J. Schwartz, Anders Hartmann, Stein Bergan
Publikováno v:
Kidney International Reports, Vol 5, Iss 2, Pp 189-198 (2020)
Introduction: There is an increasing demand for accurately measured glomerular filtration rate (GFR). Iohexol serum clearance has become a new gold standard, but it is challenging when GFR is low and 24-hour sampling is required for accurate results.
Externí odkaz:
https://doaj.org/article/bc87a5ea056547378438b35dc7e44ece
Autor:
Anders Åsberg, PhD, Stein Bergan, PhD, Magnus H. Bjørkto, MD, Geir Mjøen, MD, PhD, Anna Varberg Reisæter, MD, PhD, Ida Robertsen, PhD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 10, p e609 (2020)
Externí odkaz:
https://doaj.org/article/99bf662d935f4841bc63e88822fe6b55
Autor:
Kine Eide Kvitne, Kristine Hole, Veronica Krogstad, Birgit Malene Wollmann, Christine Wegler, Line K. Johnson, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Rune Sandbu, Jøran Hjelmesæth, Eva Skovlund, Hege Christensen, Rasmus Jansson-Löfmark, Anders Åsberg, Espen Molden, Ida Robertsen
Publikováno v:
European Journal of Clinical Pharmacology
1289–1299
1289–1299
Purpose Variability in cytochrome P450 3A4 (CYP3A4) metabolism is mainly caused by non-genetic factors, hence providing a need for accurate phenotype biomarkers. Although 4β-hydroxycholesterol (4βOHC) is a promising endogenous CYP3A4 biomarker, add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b5a692e754f48f8824d67a5bcd8e5b
https://doi.org/10.1007/s00228-022-03336-9
https://doi.org/10.1007/s00228-022-03336-9
Autor:
Kine Eide Kvitne, Ole Martin Drevland, Nora Haugli, Eline Skadberg, Hasse Khiabani Zaré, Anders Åsberg, Ida Robertsen
Publikováno v:
Clinical Pharmacokinetics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28df17335770ccbab364a78909ca6b49
https://doi.org/10.1007/s40262-023-01257-z
https://doi.org/10.1007/s40262-023-01257-z
Autor:
Markus Hovd, Ida Robertsen, Line Kristin Johnson, Veronica Krogstad, Christine Wegler, Kine Eide Kvitne, Marianne Kristiansen Kringen, Eva Skovlund, Cecilia Karlsson, Shalini Andersson, Per Artursson, Rune Sandbu, Jøran Hjelmesæth, Anders Åsberg, Rasmus Jansson-Löfmark, Hege Christensen
Publikováno v:
Clinical Pharmacokinetics
Introduction Rosuvastatin pharmacokinetics is mainly dependent on the activity of hepatic uptake transporter OATP1B1. In this study, we aimed to investigate and disentangle the effect of Roux-en-Y gastric bypass (RYGB) and weight loss on oral clearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a71b5f7a1e75507663c485c5c524a8
http://hdl.handle.net/10852/102727
http://hdl.handle.net/10852/102727
Autor:
Tommy B. Andersson, Hege Christensen, Philip Carlo Angeles, Veronica Krogstad, Shalini Andersson, Anders Åsberg, Line Kristin Johnson, Maria Vistnes, Rune Sandbu, Cecilia Karlsson, Jøran Hjelmesæth, Marianne Kristiansen Kringen, Ida Robertsen, Alexandra Peric, Rasmus Jansson-Löfmark
Publikováno v:
Journal of Pharmaceutical Sciences
Obesity is associated with comorbidities of which pharmacological treatment is needed. Physiological changes associated with obesity may influence the pharmacokinetics of drugs, but the effect of body weight on drug metabolism capacity remains uncert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ffb33de0d34a6f95e85452aed002d99
https://doi.org/10.1016/j.xphs.2020.10.027
https://doi.org/10.1016/j.xphs.2020.10.027